# Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome

> **NCT04873934** · PHASE3 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 400 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Inclisiran

## Key facts

- **NCT ID:** NCT04873934
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-24
- **Primary completion:** 2024-08-07
- **Final completion:** 2024-08-07
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2025-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04873934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04873934, "Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04873934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*